Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.40
Bid: 18.40
Ask: 18.60
Change: -0.45 (-2.39%)
Spread: 0.20 (1.087%)
Open: 18.48
High: 18.58
Low: 18.40
Prev. Close: 18.85
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Jul 2023 17:23

RNS Number : 6268H
Nanoco Group PLC
28 July 2023
 

28 July 2023

NANOCO GROUP PLC

("Nanoco", the "Group" or the "Company")

 

Exercise of Options and Issue of Shares to Employee Benefit Trust

 

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

 

Nanoco announces that it has issued 1,985,206 new Ordinary Shares of 10 pence each in the Company ("Ordinary Shares"). All of the shares were issued at par value, pursuant to a subscription by the Company's Employee Benefit Trust ('EBT') to satisfy share awards granted to employees under the Company's shareholder approved Deferred Bonus Plan. The issue of new shares enables the company to provide the shares without any cash cost and minimal dilution to existing shareholders.

On 26 July 2023 Nanoco Group plc ("Nanoco") received notice that Brian Tenner, CEO, was exercising in full options granted to him in October and December 2019. Mr Tenner's entire bonus award for the financial year ending 31 July 2019 had been issued as deferred share options which were then subject to a two year holding period. The options vested in full in October and December 2021. Details of the exercise are shown in the table below.

On 26 July 2023 Nanoco received notice that Dr Nigel Pickett, CTO, was exercising in full options granted to him in October and December 2019. Dr Pickett's entire bonus award for the financial year ending 31 July 2019 had been issued as deferred share options which were then subject to a two year holding period. Dr Pickett has also exercised options granted to him in November 2016 in respect of the deferred bonus award for the financial year ending 31 July 2016 and which were also then subject to a two year holding period. The options vested in full in November 2018. Details of the exercises are shown in the table below.

Brian Tenner, CEO, and Nigel Pickett, CTO, have both exercised their respective awards and utilised the cash proceeds of selling a proportion of shares to fund their personal tax obligations and dealing fees, while retaining the balance in full thereby increasing their shareholdings by 551,946 shares and 498,336 shares respectively.

Application was made to the FCA for the 1,985,206 new Ordinary Shares to be admitted to the premium segment of the Official List and to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on its main market for listed securities. Admission became effective on 27 July 2023, and dealings in the new Ordinary Shares have now commenced. The new Ordinary Shares rank pari passu in all respects with the existing Ordinary Shares.

Following Admission, the Company's issued share capital comprised 324,430,950 Ordinary Shares, of which 12,222 were previously held in treasury and remain so. Each Ordinary Share carries the right to one vote and, therefore, the total number of voting rights in the Company on Admission will be 324,418,728. This figure may be used by Shareholders and other investors as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The details of the awards and subsequent exercise and retention of shares are as follows:

Name of Director / PDMR

Number of options exercised

Number of shares sold to meet tax and fee obligations

Shares retained following exercise

Total shareholding

Brian Tenner (CEO - Director) - 2019 award

1,043,268

(491,322)

551,946

1,157,834

Dr Nigel Pickett (CTO - Director) 2019 award

875,362

(412,248)

463,114

11,770,911

Dr Nigel Pickett (CTO - Director) 2016 award

66,576

(31,354)

35,222

(inc above)

 

This notification is made pursuant to the Disclosure and Transparency Rules.

For further information please contact:

Liam Gray

Chief Financial Officer and Company Secretary

Telephone : +44 (0) 1928 761422

 

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots and other nano-materials. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display, Sensor and Electronics markets. An interesting property of quantum dots is their absorption spectrum. Nanoco's HEATWAVE™ quantum dots can be tuned to absorb light at different wavelengths across the near-infrared spectrum, rendering them useful for applications including image sensors. Another interesting property of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco was founded in 2001 and is headquartered in Runcorn, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

BRIAN TENNER

2.

Reason for the notification

a)

Position /status

CHIEF EXECUTIVE OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrumentIdentification code

ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

EXERCISE OF AN OPTION OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN AND SALE OF SUFFICIENT SHARES TO FUND INCOME TAX AND NATIONAL INSURANCE CHARGES. BALANCE RETAINED.

c)

Price(s) and volume(s)

Acquisition of shares on exercise of option

 Sale of shares to pay tax and costs

Price(s)

 

Volume(s)

Nil cost

18p

1,043,268

491,322

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

28 JULY 2023

f)

Place of the transaction

LONDON STOCK EXCHANGE, MAIN MARKET

Notification of Dealing Form

1.

Details of the Person Discharging Managerial Responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

DR NIGEL PICKETT

2.

Reason for the notification

a)

Position /status

CHIEF TECHNICAL OFFICER

b)

Initial notification / amendment

INITIAL NOTIFICATION

3.

Details of the Issuer

a)

Name

NANOCO GROUP PLC

b)

LEI code

213800HOSJEZO1KOCV33

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Type of instrumentIdentification code

ORDINARY SHARES OF 1O PENCE EACH

ISIN: GB00B01JLR99

b)

Nature of the transaction

EXERCISE OF AN OPTION OVER ORDINARY SHARES UNDER THE NANOCO 2015 DEFERRED BONUS PLAN AND SALE OF SUFFICIENT SHARES TO FUND INCOME TAX AND NATIONAL INSURANCE CHARGES. BALANCE RETAINED.

c)

Price(s) and volume(s)

Acquisition of shares on exercise of option

Acquisition of shares on exercise of option

 Sale of shares to pay tax and costs

Price Volume

Nil cost 875,362

 

Nil cost 66,576

18p 443,602

d)

Aggregated information:- Aggregated volume- Price

N/A

e)

Date of the transaction

28 JULY 2023

f)

Place of the transaction

LONDON STOCK EXCHANGE, MAIN MARKET

= END =

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKFBBABKDBOB
Date   Source Headline
4th Sep 20191:00 pmRNSNotice of Results
22nd Aug 20192:00 pmRNSHolding(s) in Company
15th Aug 20197:00 amRNSYear End Trading Update and Notice of Results
1st Aug 20196:15 pmRNSHolding(s) in Company
31st Jul 20197:00 amRNSContract Liability Waived
3rd Jul 20195:50 pmRNSHolding(s) in Company
27th Jun 201912:15 pmRNSHolding(s) in Company
26th Jun 20193:20 pmRNSDirector/PDMR Shareholding
26th Jun 201911:45 amRNSHolding(s) in Company
25th Jun 201912:45 pmRNSHolding(s) in Company
24th Jun 20193:45 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
24th Jun 20193:30 pmRNSHolding(s) in Company
21st Jun 20197:00 amRNSUS Customer partnership update
12th Jun 201910:25 amRNSBlock listing Interim Review
7th Jun 20194:00 pmRNSDirector/PDMR Shareholding
3rd May 20197:00 amRNSDirector/PDMR Shareholding
2nd May 20196:09 pmRNSDirector/PDMR Shareholding
18th Apr 20194:55 pmRNSDirector/PDMR Shareholding
17th Apr 20193:20 pmRNSHolding(s) in Company
17th Apr 20191:22 pmRNSHolding(s) in Company
16th Apr 20195:08 pmRNSHolding(s) in Company
11th Apr 20193:38 pmRNSHolding(s) in Company
11th Apr 20197:00 amRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSInterim Results
1st Apr 201911:40 amRNSHolding(s) in Company
12th Mar 20197:00 amRNSDirectorate Changes
4th Mar 20197:00 amRNSNotice of Results
31st Jan 20197:00 amRNSChange of Auditor
25th Jan 20197:00 amRNSContract extension signed
4th Jan 201912:18 pmRNSHolding(s) in Company
4th Jan 20197:00 amRNSPartnership with Plessey Semiconductors
24th Dec 20187:00 amRNSMilestone Achieved
13th Dec 20183:33 pmRNSResult of AGM
13th Dec 20187:00 amRNSAGM Statement
10th Dec 20184:00 pmRNSBLOCKLISTING SIX-MONTHLY RETURN
3rd Dec 201811:18 amRNSDirector Declaration
3rd Dec 20187:00 amRNSHolding(s) in Company
30th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20184:53 pmRNSHolding(s) in Company
15th Nov 20187:00 amRNSDirector/PDMR Shareholding
13th Nov 20188:15 amRNSAnnual Report and Notice of AGM
7th Nov 20181:33 pmRNSDirector/PDMR Shareholding
24th Oct 20187:00 amRNSHolding(s) in Company
17th Oct 20181:47 pmRNSDirector/PDMR Shareholding
16th Oct 201811:14 amRNSDirector/PDMR Shareholding
16th Oct 20187:00 amRNSPreliminary Results
3rd Oct 20187:00 amRNSHolding(s) in Company
24th Sep 20185:00 pmRNSHolding(s) in Company
17th Sep 20187:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.